Text Size

High Risk Breast Cancer Screening Program

This study is currently recruiting participants.
Verified May 2012 by Organisation for Oncology and Translational Research
Sponsor:
Information provided by:
Organisation for Oncology and Translational Research
ClinicalTrials.gov Identifier:
NCT00509509
First received: July 29, 2007
Last updated: May 22, 2012
Last verified: May 2012
History of Changes
  Purpose

Objectives:

  • To screen population with high risk for breast cancer
  • To promote the concept and importance of surveillance mammography
  • To find out the incidence of breast cancer in population who are in high risk for breast cancer
  • To collect blood samples for molecular analysis

Condition
Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: High Risk Breast Cancer Screening Program

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Organisation for Oncology and Translational Research:

  Eligibility

Ages Eligible for Study:   41 Years and older
Genders Eligible for Study:   Female
Sampling Method:   Probability Sample
Study Population

Women aged over 40 with high risk of breast cancer

Criteria

Inclusion Criteria:

  • Female
  • > 40 years of age
  • Women who have first-degree relative suffered from breast cancer
  • Women who have first-degree relative suffered from ovarian cancer
  • Family history of male breast cancer
  • Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40
  • Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members
  • Personal history of ovarian cancer
  • Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

  • Women with mammogram within one year
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00509509

Contacts
Contact: Louis WC Chow (852)2861 0286 lwcchow@unimed.hk

Locations
Hong Kong
UNIMED Medical Institute Recruiting
Wanchai, Hong Kong
Contact: Louis WC Chow     (852)2861 0286     lwcchow@unimed.hk    
Sponsors and Collaborators
Organisation for Oncology and Translational Research
Investigators
Principal Investigator: Louis WC Chow UNIMED Medical Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00509509     History of Changes
Other Study ID Numbers: OOTR-SBR001
Study First Received: July 29, 2007
Last Updated: May 22, 2012
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Organisation for Oncology and Translational Research:
Hereditary Breast Cancer (BRCA1, BRCA2)

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 23, 2013